IE
DRTS icon

Israel Englander’s Alpha Tau Medical DRTS Stock Holding History

Israel Englander’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-46,445
Closed -$328K – 5978
2026
Q1 		$328K Sell
46,445
-61,370
-57% -$433K ﹤0.01% 4972
2025
Q4 		$534K Buy
107,815
+70,081
+186% +$295K ﹤0.01% 4899
2025
Q3 		$170K Buy
+37,734
New +$128K ﹤0.01% 5587

Other funds holding DRTS

GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Israel Englander's DRTS Position: Q2 2026 in Review

Israel Englander sold out of Alpha Tau Medical (DRTS) in Q2 2026, closing a stake of 46,445 shares — an estimated $328K sold.

Israel Englander first reported a position in DRTS in Q3 2025 and held it in 3 quarters. The position peaked at $534K in Q4 2025. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Israel Englander reported no remaining Alpha Tau Medical position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 46,445 Alpha Tau Medical shares in Q2 2026, an estimated $328K.
  • Israel Englander first reported a position in Alpha Tau Medical in Q3 2025 and held it in 3 quarters.
  • Israel Englander's Alpha Tau Medical position peaked at $534K in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.